Vilon 20MG (Lys-Glu, the KE dipeptide) is a synthetic short peptide bioregulator for peptide transporter and docking research. In PEPT1 transporter assays Lys-Glu bound with a Ki of 1.3 mM and was carried with an EC50 of 0.53 mM, and docking models place it at the DNA sequence agat. Supplied as white lyophilized powder in a 20MG vial. CAS 45234-02-4. PubChem CID 7010502.
Out of stock
Want to be notified when this product is back in stock?
Vilon (L-lysyl-L-glutamic acid, also called Lys-Glu, KE, KE dipeptide or H-Lys-Glu-OH; CAS 45234-02-4) is a synthetic dipeptide from the Khavinson family of short peptide bioregulators. It is two L-amino acids, L-Lysine and L-Glutamic acid, joined by a single peptide bond. That makes Vilon the smallest member of the family, and it is the two-residue start of several longer bioregulator sequences, including Lys-Glu-Asp, Lys-Glu-Asp-Ala and Lys-Glu-Asp-Pro. Its chemistry is set by a balanced charge pattern: two amines, at the N-terminus and at the end of the Lysine side chain, against two carboxylic acids, on the Glutamic acid side chain and at the C-terminus. Vilon also has one feature that most short bioregulators lack: measured transporter data. In PEPT1 (SLC15A1) peptide transporter assays, Lys-Glu showed a binding affinity (Ki) of 1.3 mM (Biegel et al., 2005, PubMed 15974593), and a pharmacophore study reported it as a transported PEPT1 substrate with an EC50 of 0.53 mM (Vig et al., 2006, PubMed 16759105). Computational work adds a 26-peptide docking survey of the LAT1, LAT2 and PEPT1 transporters (Khavinson et al., 2023, PMC10046148) and a predicted DNA docking site at the four-base sequence agat (Khavinson et al., 2016, PubMed 27909961). Batch-verified at Modern Aminos, Vilon is supplied in one laboratory format:
Laboratories building Lys-Glu sequence panels often place Vilon next to other public reference listings such as Lys-Glu-Asp-Ala, (Lys-Glu-Asp-Pro) and (Ala-Glu-Asp), as well as Lys-Glu-Asp. For a walkthrough of the closest four-residue relative, see What Is ?
| Compound Name | Vilon (Lys-Glu) |
|---|---|
| Research Category | Synthetic dipeptide; Khavinson short peptide bioregulator; PEPT1 transporter and docking reference compound |
| Quantity / Formats Offered | 20MG Lyophilized Powder (Vial) |
| Synonyms / Alt Names | Lys-Glu; KE; KE dipeptide; H-Lys-Glu-OH; L-Lysyl-L-glutamic acid; lysylglutamic acid |
| CAS Number | 45234-02-4 |
| PubChem CID | 7010502 |
| ChEBI ID | CHEBI:74557 |
| UNII | H34V7IM5ML |
| Chemical Formula | C11H21N3O5 |
| Molecular Weight | 275.30 g/mol |
| Exact Mass | 275.1481 Da |
| IUPAC Name | (2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]pentanedioic acid |
| InChIKey | UGTZHPSKYRIGRJ-YUMQZZPRSA-N |
| SMILES Code | C(CCN)CC(C(=O)NC(CCC(=O)O)C(=O)O)N (2 defined stereocenters, both L (S); see the InChIKey) |
Identity fields are drawn from PubChem CID 7010502 and ChEBI; purity and quantity values come from the lot certificates in the Certificate of Analysis tab.
The biochemical targets and pathway logic of Vilon in laboratory research include:
| PEPT1 Ki | 1.3 mM | not reported | Biegel 2005 |
|---|---|---|---|
| PEPT1 Gly-Sar uptake IC50 | 0.82 mM | not reported | Vig 2006 |
| PEPT1 transport EC50 (max vs Gly-Sar) | 0.53 mM (121%) | not reported | Vig 2006 |
| ICM-Score, LAT1 (kcal/mol analogue) | −19.02 | −28.83 | Khavinson 2023, Table 1 |
| ICM-Score, LAT2 | −23.94 | −21.45 | Khavinson 2023, Table 3 |
| ICM-Score, PEPT1 | −17.02 | −16.70 | Khavinson 2023, Table 5 |
| Predicted DNA docking site | agat | not reported | Khavinson 2016 |
Peer-reviewed literature on Vilon 20MG and its Lys-Glu sequence centers on transporter assays, molecular docking, sequence bioinformatics and chemical identity:
To map transporter binding, DNA docking and sequence-length effects, researchers compare Vilon against other short peptide bioregulators, including several available at Modern Aminos:
| Compound / Reference | Primary Target Class | Core Mechanism of Action | Research Focus & Profile |
|---|---|---|---|
| Vilon 20MG (Lys-Glu, KE) | Dipeptide bioregulator; Lys-Glu core | Measured PEPT1 substrate (Ki 1.3 mM; EC50 0.53 mM); docked LAT1 −19.02, LAT2 −23.94, PEPT1 −17.02; DNA site agat | Smallest Lys-Glu sequence; zwitterionic; the one member with measured transporter data |
DISCLAIMER: All compounds and research materials provided by Modern Aminos are strictly for laboratory and research use only. They are not approved for human consumption by the Food and Drug Administration (FDA). No products are approved for oral, sublingual, nor in vivo use. These products should not be used for any form of in vivo experimentation or for any other non-laboratory purpose. Any violation or indication of human or animal use will result in immediate removal from being able to purchase products in the future. By purchasing these products, you acknowledge that they will be used exclusively within a controlled and qualified research environment.